Eli Lilly and Co (LLY)

LLY (NYSE:Drugs)
$71.74
neg -0.37
-0.51%
Today's Range: 71.45 - 72.14 | LLY Avg Daily Volume: 4,718,400
Last Update: 01/27/15 - 3:59 PM EST
Volume: 3,637,845
YTD Performance: 4.52%
Open: $71.76
Previous Close: $72.11
52 Week Range: $52.29 - $75.10
Oustanding Shares: 1,113,429,817
Market Cap: 80,311,692,700
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 6 6 6
Moderate Buy 1 1 0 0
Hold 9 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1
Mean Rec. 2.23 2.10 2.29 2.29
Latest Dividend: 0.50
Latest Dividend Yield: 2.77%
Dividend Ex-Date: 02/11/15
Price Earnings Ratio: 28.85
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
28.85 28.80 25.92
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.17% 33.24% 82.83%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.30 0.00 0.00
Net Income 14.60 -0.08 -0.03
EPS 18.00 -0.05 -0.02
Earnings for LLY:
EBITDA 6.99B
Revenue 23.11B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.74 $0.74 $2.78 $3.12
Number of Analysts 8 2 12 12
High Estimate $0.77 $0.81 $2.80 $3.22
Low Estimate $0.70 $0.67 $2.73 $2.90
Prior Year $0.74 $0.70 $4.15 $2.78
Growth Rate (Year over Year) -0.51% 5.71% -32.97% 12.22%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
Jan 15, 2015 | 7:08 AM EST
LLY was upgraded to Neutral, Goldman Sachs said. $70 price target. Company is improving margins and can deliver double-digit annual ear...
Bearish
Jan 09, 2015 | 7:08 AM EST
LLY was downgraded to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $74 price target. 
Bearish
Jan 08, 2015 | 8:01 AM EST
LLY was downgraded from Buy to Hold, Deutsche Bank said. $75 price target. Valuation call, as the stock gained 35% in 2014. 
Bullish
Jan 08, 2015 | 7:48 AM EST
LLY was upgraded to Buy, Jefferies said. $80 price target. Company has an attractive pipeline and can expand margins. 

Lilly Cuts Guidance Real Money Pro($)

Break in!

This Morning's Market Setup Real Money Pro($)

The rundown.
Bullish
Dec 22, 2014 | 7:59 AM EST
Shares of LLY now seen reaching $76, according to Leerink Partners. Estimates also upped, given the company's solid clinical pipeline. ...
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
Bullish
Dec 11, 2014 | 7:24 AM EST
LLY was upgraded from Underweight to Overweight, Morgan Stanley said. $85 price target. Prospects of the company's pipeline are underva...
Get a head start on upcoming ex-dividend days.

Columnist Conversations

On day's high and +$1.24 on the day.
GIS
this stock is unnaturally strong --domestic with yield--but there is no option activity so I would normally di...
Market recovering slightly from deep early losses, but indices still lower than where they began the day at. A...
S&P futures bounced inside our zone @ 2020.30-2011.10. The S&P futures are not short term oversold yet...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.